RT @NatRevClinOncol: Endothelial E-selectin inhibition improves acute myeloid leukaemia therapy by disrupting vascular niche-mediated chemo…
@alex_tonks
RT @NatRevClinOncol: Endothelial E-selectin inhibition improves acute myeloid leukaemia therapy by disrupting vascular niche-mediated chemo…
RT @NatRevClinOncol: Endothelial E-selectin inhibition improves acute myeloid leukaemia therapy by disrupting vascular niche-mediated chemo…
Endothelial E-selectin inhibition improves acute myeloid leukaemia therapy by disrupting vascular niche-mediated chemoresistance: https://t.co/XeFmcO8cxq #leusm #camicroenv #hemeonc
RT @MichaelodwyerMD: Endothelial E-selectin inhibition improves acute myeloid leukaemia therapy by disrupting vascular niche-mediated chemo…
Endothelial E-selectin inhibition improves acute myeloid leukaemia therapy by disrupting vascular niche-mediated chemoresistance | Nature Communications #AML #glycotime https://t.co/FJub99hRgf
RT @kiakho: Amazing work by Ingrid Winkler at UQ mater about Endothelial E-selectin inhibition. Well done. @UQMedicine @TRI_info https…
Endothelial E-selectin inhibition improves acute myeloid leukaemia therapy by disrupting vascular niche-mediated chemoresistance. https://t.co/DEvmdbecRc
New article: Endothelial E-selectin inhibition improves acute myeloid leukaemia therapy by disrupting vascular niche-mediated chemoresistance. https://t.co/nmj1YG9EvX #AML #leusm #hematology
RT @kiakho: Amazing work by Ingrid Winkler at UQ mater about Endothelial E-selectin inhibition. Well done. @UQMedicine @TRI_info https…
RT @_atanas_: Endothelial E-selectin inhibition improves acute myeloid leukaemia therapy by disrupting vascular niche-mediated chemoresista…
RT @endothelialnews: From @MaterResearch: Using acute myeloid leukemia (AML) mouse models, the authors showed AML blasts released inflammat…
From @MaterResearch: Using acute myeloid leukemia (AML) mouse models, the authors showed AML blasts released inflammatory mediators that upregulated endothelial niche E-selectin expression. @NatureComms https://t.co/b9vS8II6Yd https://t.co/Iv5Mn2vP8w
RT @_atanas_: Endothelial E-selectin inhibition improves acute myeloid leukaemia therapy by disrupting vascular niche-mediated chemoresista…
Great study by Ingrid Winkler @MaterResearch showing how E-selectin blockade improves chemotherapy to AML
RT @_atanas_: Endothelial E-selectin inhibition improves acute myeloid leukaemia therapy by disrupting vascular niche-mediated chemoresista…
RT @_atanas_: Endothelial E-selectin inhibition improves acute myeloid leukaemia therapy by disrupting vascular niche-mediated chemoresista…
RT @_atanas_: Endothelial E-selectin inhibition improves acute myeloid leukaemia therapy by disrupting vascular niche-mediated chemoresista…
RT @_atanas_: Endothelial E-selectin inhibition improves acute myeloid leukaemia therapy by disrupting vascular niche-mediated chemoresista…
RT @_atanas_: Endothelial E-selectin inhibition improves acute myeloid leukaemia therapy by disrupting vascular niche-mediated chemoresista…
Endothelial E-selectin inhibition improves acute myeloid leukaemia therapy by disrupting vascular niche-mediated chemoresistance #Endothelial #Leukaemia #Chemoresistance Other social media channels: https://t.co/Qs12PWtaqx https://t.co/ffcivgFBqg
RT @kiakho: Amazing work by Ingrid Winkler at UQ mater about Endothelial E-selectin inhibition. Well done. @UQMedicine @TRI_info https…
Amazing work by Ingrid Winkler at UQ mater about Endothelial E-selectin inhibition. Well done. @UQMedicine @TRI_info https://t.co/TqXJJtGN98
Read the full paper published today in @NatureComms. Authors also from @MonashUni @Sydney_Uni #RoyalPrinceAlfredHospital @CancerDartmouth & #GlycoMimetics https://t.co/X5tJNh9XsT